The FDA has granted Google’s (NSDQ:GOOGL) Verily emergency use authorization (EUA) for its pooled COVID-19 testing. In a letter to the company dated yesterday, the FDA confirmed the EUA status for the qualitative test for detecting nucleic acid from SARS-CoV-2 in respiratory specimens procured through nasal, mid-turbinate, nasopharyngeal and oropharyngeal swabbing. The test also can be […]
Verily
Verily launches clinical lab for COVID-19 testing
Google’s (NSDQ:GOOGL) Verily announced that it established a CLIA-certified lab to create additional lab capacity to support COVID-19 testing. The lab, at Verily’s San Francisco headquarters, is designed to support programs in the COVID-19 testing space as demand continues to increase while the pandemic goes on, including the company’s own return-to-work efforts for its own employees, […]
LivaNova adds Verily to depression study
LivaNova (NSDQ:LIVN) announced that it has added Google’s (NSDQ:GOOGL) Verily to its study of vagus nerve stimulation (VNS) therapy for difficult-to-treat depression (DTD). The Recover clinical will gather quantitative data on patient behavior using Verily’s technology and analytics. The data could help the researchers understand depressive episodes and the patient’s response to treatment. Study participants will […]
Verily, Santen do a JV for ophthalmological devices
Santen Pharmaceutical (OTC:SNPHY) and Verily, an Alphabet (NSDQ:GOOGL) company, announced that they are entering into a joint venture to focus on applying microelectronics and scalable digital technologies to ophthalmology. Osaka, Japan-based Santen and San Francisco-based Verily say they want to improve eye health globally. According to a news release, the joint venture is slated to combine […]
New 510(k) boosts iRhythm, Verily efforts for AFib screening
The latest 510(k) clearance for the Verily Study Watch will further the efforts of the Google sister company and iRhythm Technologies (NSDQ:IRTC) to improve atrial fibrillation treatment. Verily — a life science company under Alphabet (NSDQ:GOOGL) — recently received an FDA 510(k) clearance to include an irregular pulse monitor in its Study Watch wearable. “We’ve worked carefully […]
FDA clears Verily Study Watch for additional capabilities
Verily, Google’s life science’s sister company under Alphabet (NSDQ:GOOGL), has received an FDA 510(k) clearance to include an irregular pulse monitor in its Study Watch wearable. The FDA announcement, last updated Jan. 20, did not include additional information. The agency cleared ECG capabilities on the Study Watch in January 2019. Launched in April 2017, the Study […]
Earlens to partner with Verily for next-gen Earlens hearing device
Earlens today said it entered a strategic agreement with Verily to develop next-generation capabilities for the Earlens Contact Hearing Solution. Earlens’s Contact Hearing Solutions directly activates the hearing system to deliver the broadest bandwidth in a nonsurgical hearing solution. It uses a small lens to vibrate the eardrum to replicate the natural hearing process. “Unlike […]
Verily hires former Tesla executive as CFO
Verily — Google’s life sciences sister company under Alphabet (NSDQ:GOOG) — has hired Tesla veteran Deepak Ahuja as its CFO, according to a report on CNBC. Ahuja previously served two stints as CFO at Tesla. He left Tesla in early 2019 and was serving as a senior advisor to Capricorn Investment Group, according to his LinkedIn […]
iRhythm releases delayed Q3 earnings report, falls short of Street projections
iRhythm Technologies (NSDQ:IRTC) shares are slightly up today on third-quarter results that came up short of the consensus forecast. The San Francisco-based company delayed its third-quarter report in November due to a previously disclosed material weaknesses. At the time, the company said it identified errors that affected prior periods while preparing the quarterly report for the […]
J&J to acquire remaining stake in Verb Surgical
Johnson & Johnson (NYSE:JNJ) announced today that it agreed to acquire the remaining stake in Verb Surgical, following a successful strategic collaboration with Alphabet (NSDQ:GOOGL) life sciences unit Verily. Verb Surgical’s robotics and data science capabilities were the driving force behind Johnson & Johnson’s decision to combine with the company as it seeks to advance medical interventions, making […]
Sanofi backs away from diabetes partnership with Verily
Three years after investing $248 million in a Type 2 diabetes joint venture with Google’s (NSDQ:GOOGL) Verily Life Sciences, , Sanofi (NYSE:SNY) is backing out. The drug company’s new CEO made the announcement during a capital markets meeting yesterday, saying the company had over-invested in the virtual diabetes clinic, Onduo, according to published reports. Sanofi will […]
